Moderna, Inc. - Common Stock (NQ:MRNA)

190.79 -12.42 (-6.11%)

Delayed Quote Updated: 10:42 AM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

99 100 Next >

Moderna Brings Back Drug Product Manufacturing To Home Ground ↗

November 19, 2025

The company said it has commenced construction at the Massachusetts facility, which is slated for completion in the first half of 2027.

Via Stocktwits

Moderna Expands U.S. Manufacturing with Onshoring of Drug Product Capabilities

November 19, 2025

Via ACCESS Newswire

Moderna to Present at Upcoming Piper Sandler's 37th Annual Healthcare Conference on December 2, 2025

November 18, 2025

Via ACCESS Newswire

1 Cash-Heavy Stock to Target This Week and 2 That Underwhelm

November 16, 2025

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining...

Via StockStory

Friday's session: gap up and gap down stock in the S&P500 index ↗

November 14, 2025

Wondering which stocks are making significant price gaps? Explore the S&P500 index on Friday to find the gap up and gap down stocks in today's session.

Via Chartmill

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

The Tech Tsunami: How Breakthroughs in AI, Quantum, and Green Energy Are Reshaping the Stock Market

November 14, 2025

The global financial markets are in the midst of a profound transformation, driven by an accelerating wave of technological advancements. From the intricate algorithms of Artificial Intelligence to the...

Via MarketMinute

Merck Makes Big Bet On Flu Protection With Cidara Buyout ↗

November 14, 2025

Merck (NYSE: MRK) to acquire Cidara (NASDAQ: CDTX) for $9.2 billion, diversifying its portfolio with CD388.

Via Benzinga

5 Insightful Analyst Questions From Moderna’s Q3 Earnings Call

November 13, 2025

Moderna’s third quarter was shaped by sharply lower demand for COVID-19 vaccines, yet the company delivered results above Wall Street expectations for both revenue and earnings. Management attributed...

Via StockStory

Topics Earnings

3 Small-Cap Stocks with Warning Signs

November 12, 2025

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

Via StockStory

Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know

November 11, 2025

A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...

Via StockStory

Topics Artificial Intelligence Stocks

Exploring the top movers within the S&P500 index during today's session. ↗

November 11, 2025

Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.

Via Chartmill

Q3 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks

November 10, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Moderna (NASDAQ:MRNA) and its peers.

Via StockStory

Topics Artificial Intelligence

Healthcare Sector Navigates Turbulent Waters: Innovation Surges Amidst Political Headwinds

November 10, 2025

New York, NY – November 10, 2025 – The S&P 500 Healthcare sector presented a mixed picture today, with the broader index showing a modest uptick while significant segments, particularly health insurers...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Telemark Asset Management Builds Position in Beaten-Down Biotech Stock. ↗

November 10, 2025

Telemark Asset Management Builds Position in Beaten-Down Biotech Stock.

Via The Motley Fool

Topics Regulatory Compliance

S&P 500 Breaches Key Support: A Signal of Deepening Market Weakness

November 07, 2025

The S&P 500 index has recently fallen below its crucial 50-day moving average, a technical event that is sending ripples of concern throughout global financial markets. This breach, occurring as of...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

Wall Street Slips as Job Cuts and Shutdown Fears Shake Confidence ↗

November 07, 2025

Investors brace for weaker labor data and prolonged government paralysis while AI-fueled volatility rattles the markets.

Via Chartmill

MRNA Q3 Deep Dive: Cost Controls and Pipeline Progress Amid Declining COVID Vaccine Demand

November 07, 2025

Biotechnology company Moderna (NASDAQ:MRNA) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales fell by 45.4% year on year to $1.02 billion. On the other hand, the company’s...

Via StockStory

AI Stocks Slide Again, Bitcoin Dips Near $100,000: What's Moving Markets Thursday? ↗

November 06, 2025

After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, with AI-linked stocks leading a broad selloff across Wall Street and renewed pressure hitting crypto...

Via Benzinga

Topics Artificial Intelligence

mRNA Vaccine Maker Moderna Lowers R&D Spending, Tightens Sales Forecast ↗

November 06, 2025

Moderna posts a smaller Q3 loss, trims 2025 sales forecast, cuts R&D costs, and boosts cash outlook as COVID vaccine demand declines.

Via Benzinga

Moderna Q3 2025 Earnings Call Transcript ↗

November 06, 2025

Moderna reported third-quarter financial results on Thursday. The transcript from the company's earnings call has been provided below.

Via Benzinga

Topics Earnings

Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗

November 06, 2025

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.

Via Chartmill

Moderna Inc (NASDAQ:MRNA) Reports Q3 2025 Revenue Beat and Narrower-Than-Expected Loss ↗

November 06, 2025

Moderna's Q3 2025 earnings beat revenue estimates with $1.016B and a narrower loss. Shares rose on strong COVID vaccine sales and an improved 2025 financial outlook.

Via Chartmill

Topics Earnings

Moderna Surges; Covid Vaccine Sales Decline, But Top Expectations ↗

November 06, 2025

Moderna stock surged Thursday. Though third-quarter vaccine sales declined, they came in above expectations.

Via Investor's Business Daily

Moderna (NASDAQ:MRNA) Posts Better-Than-Expected Sales In Q3, Stock Soars

November 06, 2025

Biotechnology company Moderna (NASDAQ:MRNA) beat Wall Street’s revenue expectations in Q3 CY2025, but sales fell by 45.4% year on year to $1.02 billion. On the other hand, the company’s full-year...

Via StockStory

Topics Artificial Intelligence Supply Chain

Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates

November 06, 2025

Via ACCESS Newswire

Services Sector Soars, Dispelling Economic Gloom and Fueling U.S. Stock Market Rally

November 05, 2025

Washington D.C., November 5, 2025 – The U.S. services sector has delivered a powerful jolt of optimism to financial markets, with robust Purchasing Managers' Index (PMI) data for October 2025 largely...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

10 Health Care Stocks Whale Activity In Today's Session ↗

November 05, 2025

Via Benzinga

AI Achieves Atomic Precision in Antibody Design: A New Era for Drug Discovery Dawns

November 05, 2025

Seattle, WA – November 5, 2025 – In a monumental leap for biotechnology and artificial intelligence, Nobel Laureate David Baker’s lab at the University of Washington’s Institute for Protein Design...

Via TokenRing AI

Topics Artificial Intelligence Intellectual Property

Moderna Earnings: What To Look For From MRNA

November 04, 2025

Biotechnology company Moderna (NASDAQ:MRNA) will be reporting results this Thursday before the bell. Here’s what investors should know.

Via StockStory

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.